# Strategies To Prevent Cardiac Allograft Vasculopathy Related Events in Heart Transplant Recipients

> **NCT01305395** · NA · WITHDRAWN · sponsor: **University of Minnesota**

## Conditions studied

- Cardiac Allograft Vasculopathy

## Interventions

- **DRUG:** Sirolimus
- **DRUG:** Sirolimus
- **DRUG:** Sirolimus
- **DRUG:** Sirolimus
- **DRUG:** Sirolimus

## Key facts

- **NCT ID:** NCT01305395
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-11
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Due in part, to reduced transplant volume and enrollment has been difficult.
- **Last updated:** 2017-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01305395

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01305395, "Strategies To Prevent Cardiac Allograft Vasculopathy Related Events in Heart Transplant Recipients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01305395. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*